2874-72-8 Usage
Description
2-Decyldodecanoic Acid, also known as 2-DDA, is a long-chain fatty acid with a unique structure featuring a decyl side chain attached to a dodecanoic acid backbone. It is a synthetic compound with specific chemical properties that make it suitable for various applications in different industries.
Uses
Used in Pharmaceutical Industry:
2-Decyldodecanoic Acid is used as a reactant for the synthesis of Vizantin, a compound developed as a safe immunostimulant. It plays a crucial role in enhancing the immune response and has potential applications in the treatment of various diseases and conditions.
Used in Chemical Synthesis:
2-Decyldodecanoic Acid can be utilized as a building block in the synthesis of various complex organic compounds, such as surfactants, lubricants, and additives. Its unique structure and properties make it a valuable component in the development of new materials with specific characteristics and functions.
Check Digit Verification of cas no
The CAS Registry Mumber 2874-72-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,7 and 4 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 2874-72:
(6*2)+(5*8)+(4*7)+(3*4)+(2*7)+(1*2)=108
108 % 10 = 8
So 2874-72-8 is a valid CAS Registry Number.
2874-72-8Relevant articles and documents
Development of vizantin, a safe immunostimulant, based on the structure-activity relationship of trehalose-6,6′-dicorynomycolate
Yamamoto, Hirofumi,Oda, Masataka,Nakano, Mayo,Watanabe, Naoyuki,Yabiku, Kenta,Shibutani, Masahiro,Inoue, Masahisa,Imagawa, Hiroshi,Nagahama, Masahiro,Himeno, Seiichiro,Setsu, Kojun,Sakurai, Jun,Nishizawa, Mugio
supporting information, p. 381 - 385 (2013/02/23)
Vizantin, 6,6′-bis-O-(3-nonyldodecanoyl)-α,α′- trehalose, was developed as a safe immunostimulator on the basis of a structure-activity relationship (SAR) study with trehalose 6,6′- dicorynomycolate (TDCM). It was possible to synthesize vizantin on a large scale more easily than in the case of TDCM, and the compound exhibited more potent prophylactic effect on experimental lung metastasis of B16-F0 melanoma cells. Because vizantin stimulated human macrophages, it is a promising candidate for clinical application.
TREHALOSE COMPOUND, PROCESS FOR PRODUCTION OF THE COMPOUND, AND IMMUNO-STIMULATIVE AGENT COMPRISING THE COMPOUND
-
Page/Page column 14-15, (2009/12/07)
An object of the present invention is to provide a novel trehalose compound that exhibits excellent immunostimulating activity and that can be supplied in a large quantity in an industrial scale, and a method for producing the trehalose compound, wherein
